Benefits of concurrent syringe exchange and substance abuse treatment participation.
Participation in syringe exchange programs (SEPs) is associated with many individual and public health benefits but may have little impact on reducing drug use without concurrent treatment engagement. This study evaluated rates of drug use, other risk behaviors, and illegal activities in newly registered SEP participants (N = 240) enrolled versus not enrolled in substance abuse treatment over a 4-month observation window and examined the effect of days in treatment on these outcomes. After controlling for baseline differences, SEP registrants enrolled in treatment (n = 113) reported less days of opioid and cocaine use, injection drug use, illegal activities, and incarceration than those not enrolled in treatment (n = 127). For those enrolled in treatment, days of treatment was strongly correlated with each of these outcomes. These findings provide good evidence for a dose-response effect of treatment in syringe exchangers and suggest that substance abuse treatment significantly expands the harm reduction benefits of SEP participation.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, MD, USA. mkidorf@jhmi.edu
Michael
M
Kidorf
Van L
VL
King
Jessica
J
Peirce
Jessica
J
Pierce
Ken
K
Kolodner
Robert K
RK
Brooner
D000328:Adult; D019970:Cocaine-Related Disorders / Q000453:epidemiology / Q000534:rehabilitation; D003415:Crime / Q000706:statistics & numerical data*; D005260:Female; D005500:Follow-Up Studies; D040261:Harm Reduction; D006801:Humans; D008297:Male; D018671:Needle-Exchange Programs / Q000706:statistics & numerical data*; D009293:Opioid-Related Disorders / Q000453:epidemiology / Q000534:rehabilitation; D011329:Prisoners / Q000706:statistics & numerical data; D012309:Risk-Taking; D015819:Substance Abuse, Intravenous / Q000453:epidemiology* / Q000534:rehabilitation; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000534:rehabilitation; D013997:Time Factors
Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004145
15495080
Drug Alcohol Depend. 2004 May 10;74(2):115-22
15099655
Am J Epidemiol. 1997 Dec 15;146(12):994-1002
9420522
Drug Alcohol Depend. 2006 Jul 27;83(3):225-32
16364566
Lancet. 1996 Oct 12;348(9033):987-91
8855855
AIDS Behav. 2005 Dec;9(4):495-504
16237501
J Subst Abuse Treat. 2003 Jan;24(1):67-74
12646332
J Subst Abuse Treat. 1992;9(3):199-213
1334156
Drug Alcohol Depend. 2010 Jun 1;109(1-3):154-60
20163922
JAMA. 2000 Oct 4;284(13):1689-95
11015800
Subst Use Misuse. 2006;41(6-7):777-813
16809167
Public Health Rep. 1998 Jun;113 Suppl 1:129-39
9722818
Am J Addict. 2006 Mar-Apr;15(2):113-24
16595348
Drug Alcohol Depend. 2008 Sep 1;97(1-2):122-9
18486360
Drug Alcohol Depend. 1995 Dec;40(2):139-50
8745136
Arch Gen Psychiatry. 2001 May;58(5):503-8
11343531
J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):229-37
12571535
Am J Epidemiol. 1999 Feb 1;149(3):203-13
9927214
Addiction. 2003 May;98(5):673-84
12751985
Drug Alcohol Depend. 2000 Apr 1;59(1):17-31
10706972
Drug Alcohol Depend. 1997 Sep 25;47(3):227-35
9306048
J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):199-205
12794555
Arch Gen Psychiatry. 2006 Jan;63(1):102-9
16389204
Addiction. 2009 Sep;104(9):1441-6
19215605
AIDS Educ Prev. 2007 Apr;19(2):111-23
17411414
AIDS. 2001 Jul 27;15(11):1329-41
11504954
Addiction. 2009 May;104(5):786-95
19413790
J Subst Abuse Treat. 2003 Jun;24(4):305-11
12867204
AIDS. 2002 Apr 12;16(6):941-3
11919503
Addict Behav. 2010 May;35(5):499-503
20079972
J Subst Abuse. 2000;11(3):215-30
11026121
Can J Psychiatry. 2008 Aug;53(8):487-95
18801210
J Urban Health. 2005 Sep;82(3):456-67
16014875
AIDS. 2000 Mar 31;14(5):605-11
10780722
J Subst Abuse Treat. 2000 Oct;19(3):247-52
11027894
JAMA. 1994 Jan 12;271(2):115-20
8264065
J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):237-42
12394803
J Acquir Immune Defic Syndr. 2007 May 1;45(1):108-14
17460474
Addiction. 2007 Sep;102(9):1454-62
17697278
Arch Gen Psychiatry. 1997 Jan;54(1):71-80
9006403
J Subst Abuse Treat. 1998 May-Jun;15(3):183-91
9633030
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):157-64
9241116
J Consult Clin Psychol. 2001 Jun;69(3):389-405
11495169